LUMOS PHARMA, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Lumos Pharma, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2010 to Q3 2024.
  • Lumos Pharma, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 8.33M shares, a 4.38% increase year-over-year.
  • Lumos Pharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 8.15M shares, a 2.73% decline from 2022.
  • Lumos Pharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 8.37M shares, a 0.47% increase from 2021.
  • Lumos Pharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 8.33M shares, a 23% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 8.33M +349K +4.38% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 8.11M -52K -0.64% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-02
Q1 2024 8.1M -135K -1.64% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 8.15M -229K -2.73% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 7.98M -410K -4.88% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 8.16M -202K -2.41% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-02
Q1 2023 8.24M -118K -1.41% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 8.37M +39.3K +0.47% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 8.39M +30.6K +0.37% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 8.37M -366K -4.19% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 8.36M +41.1K +0.49% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 8.33M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-07
Q3 2021 8.36M +64.1K +0.77% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 8.73M +439K +5.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 8.32M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q3 2020 8.29M +6.95M +517% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 8.29M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q3 2019 1.34M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q1 2017 29.2M +357K +1.24% Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-05
Q4 2016 29M +393K +1.37% Oct 1, 2016 Dec 31, 2016 10-K 2017-03-06
Q3 2016 29M +249K +0.87% Jul 1, 2016 Sep 30, 2016 10-Q 2016-11-08
Q2 2016 28.9M +230K +0.8% Apr 1, 2016 Jun 30, 2016 10-Q 2016-08-05
Q1 2016 28.9M +638K +2.26% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-05
Q4 2015 28.6M Oct 1, 2015 Dec 31, 2015 10-K 2017-03-06
Q3 2015 28.7M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 28.7M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 28.2M +613K +2.22% Jan 1, 2015 Mar 31, 2015 10-Q 2016-04-29
Q1 2014 27.6M Jan 1, 2014 Mar 31, 2014 10-Q/A 2015-08-24
Q4 2012 20.8M +14.7M +243% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-16
Q3 2012 20.9M +17.2M +471% Jul 1, 2012 Sep 30, 2012 10-Q 2012-10-31
Q2 2012 20.7M +17M +467% Apr 1, 2012 Jun 30, 2012 10-Q 2012-08-14
Q1 2012 20.6M +17M +467% Jan 1, 2012 Mar 31, 2012 10-Q 2012-05-10
Q4 2011 6.06M Oct 1, 2011 Dec 31, 2011 10-K 2012-03-30
Q3 2011 3.66M +286K +8.49% Jul 1, 2011 Sep 30, 2011 10-Q 2012-10-31
Q2 2011 3.65M Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 3.64M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10
Q3 2010 3.37M Jul 1, 2010 Sep 30, 2010 10-Q/A 2012-01-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.